Sign up for our free weekly newsletter
Informed comment and
independent news delivered
by email every week.
Sign up here.
Find out more about Poweralts Forums
Management and investors
are brought together at our
investor forums.
Find out more.
Bulletin Board
Join other informed investors.
Debate energy companies.
Visit Bulletin Boards.
Terrapinn Commodity Investment World
The Munro Fund
Ambrian Capital
allipo.com
Adopt an Acre - Become a Rainforest Guardian

Company Information for TMO Renewables Limited


Company Statement

TMO Renewables Limited is a leader in the development of second generation sustainable biofuels. TMO’s process is capable of utilising all of the sugars, including complex longer chain forms, derived from biomass and their high temperature process is capable of producing fuel ethanol at high efficiency and high conversion rates. TMO intends to build the UK’s first cellulosic ethanol Process Demonstation Unit during 2007 which will integrate all the necessary steps in a continuous ethanol production process. TMO’s integrated sustainable approach to ethanol production utilises readily available and low cost biomass feedstocks. Furthermore, the process can be a net energy contributor by applying energy recovery techniques.




Board of Directors and Key Management

Hamish Curran, Chief Executive Officer
Hamish joined TMO in 2006 with over 20 years of international management and consulting experience in the energy and renewables sector. Hamish joined from Argent Energy, where he was Chief Operating Officer and was responsible for the construction, start-up and commissioning of the first industrial scale bio-diesel plant in the UK. Prior positions have included Managing Director for WaveGen, General Manager within British-Borneo Oil & Gas plc, General Manager and Asset Director for JKX &Gas plc.
A former member of the UK Government Oil & Gas Industry Task force, Hamish has broad experience of cross border projects as well as a consulting record demonstrating the ability to identify and deliver measurable improvement at board level and at “shop floor”. Hamish has delivered results ranging from major corporate M&A activity to focussed strategic asset advice and analysis.
Christopher Miller, Chairman / non-executive Director
Age 54, he qualified as a chartered accountant with Coopers & Lybrand, following which he was an Associate Director of Hanson plc. In September 1988 he joined the Board of Wassall PLC as its Chief Executive. Between October 2000 and May 2003 he was involved in private investment activities. Mr Miller was appointed as an executive Director of Melrose on 29 May 2003. He is currently Chairman of Melrose plc.
Dr. Anthony Atkinson B.Sc., Ph.D, FIIB, FIoN, Research & Development Director
After 25 years with the UK Centre for Applied Microbiology and Research (CAMR) where he was Deputy Director and Director of the Commercial Biotechnology Division, Tony moved on in 1994 to pursue his industrial and commercial interests. Tony has consulted for Schering-Plough, DuPont and ICI and was on UK regulatory and advisory committees in biosciences and nanotechnology. A former member of the Advisory Board of Merlin Ventures, Tony has interests in several other biotech companies. Tony was CEO of Enact Pharma PLC, which acquired Enzacta PLC and was later sold to Protherics PLC. He is currently Non-Executive director of Biofusion Plc and Chairman of Morvus Technology Limited. Tony has published over 400 scientific papers and registered 20 patents, many of which are licensed to the likes of Boehringer, Biogen and DuPont. Over 120 of these papers relate to the biotechnology of thermophiles and their products. TMO benefits from Tony’s unique experience in thermophile genetics and manipulation. Tony is also responsible for TMO’s patent and IP strategy and all laboratory research.

Company Address

40 Alan Turing Road, Surrey Research Park
Guildford, Surrey, United Kingdom GU2 7YF

Telephone:+44 (1483) 303305
Facsimile:+44 (0)1483 307795
Website:http://www.tmo-group.com

Most Recent Statement

02/07/07 - TMO Renewables licenses ERGO genomics platform to enhance cellulosic ethanol production using microbial genomes
06/05/07 - Completion of Fundraising. Announcing the UK’s first process demonstration unit for cellulosic ethanol

To top